In this retrospective cohort study, patients with COPD who were seen during the 2010 calendar year at family medicine and internal medicine outpatient offices of an academic medical center were ...

SAN DIEGO -- The beta-blocker bisoprolol did not improve exacerbations in chronic obstructive pulmonary disease (COPD) patients, a randomized clinical trial found. Exacerbations requiring antibiotics, ...

Please provide your email address to receive an email when new articles are posted on . Bisoprolol use in COPD was deemed “not clinically beneficial” by researchers. In both the bisoprolol group and ...

Please provide your email address to receive an email when new articles are posted on . Studies on the beta-blocker bisoprolol and dupilumab presented at the ATS Conference gained attention from ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...